Q-omics provides the consensus-scored RNU6-65P profile across patient tissues and cancer cell-line models. RNU6-65P expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, RNU6-65P RNA expression shows 5,815 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight TGCT, and STAD as cancer lineages where RNU6-65P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-65P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-65P survival associations across molecular data types. RNU6-65P RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-65P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	TGCT (18)	view →

This table ranks reproducible RNU6-65P RNA expression–survival associations across cancer types. High RNU6-65P expression shows unfavorable associations in TGCT, SARC, LGG, BRCA and THCA, but favorable associations in ESCA. The TGCT Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify TGCT as the clearest survival context for RNU6-65P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	All	0.035	0.837	<.001	18	view →
SARC	OS	Tertile	All	0.133	0.860	<.001	18	view →
LGG	OS	Tertile	All	0.409	0.836	<.001	18	view →
BRCA	OS	Tertile	All	0.185	0.579	.037	12	view →
THCA	DFS	Tertile	II,III,IV	0.650	0.907	.044	9	view →
ESCA	OS	Tertile	III,IV	1.000	0.376	.048	6	view →

Pink = unfavorable, green = favorable. all 7 lineages →

RNU6-65P-TGCT (DFS)

Kaplan–Meier survival curve for RNU6-65P RNA expression in TGCT: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-65P in patient tissues and cancer cell lines. In patient samples, RNU6-65P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,815	STAD (5666)	view →
RNA	4,144	STAD (1085)	view →